Key Definitions GLP-1 microdosing refers to using doses below the validated initiation levels studied in large randomized clinical trials of GLP-1 receptor agonists such as semaglutide and tirzepatide
4 The economics of metabolic dominance The financial gravity of GLP-1 therapies is reshaping corporate balance sheets
Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH
Genevas clinicians evaluate your health, appetite patterns, and metabolic needs before recommending the medication best suited for your goals
Now, where we're at today is that we do have some encouraging signals in both imaging and some small trials
We believe that one of the important mechanisms underlying this effect is likely reduction of inflammation in the fatty tissue around the heart, which we know is an important driver of arrhythmias and other unwanted cardiac outcomes. Bilchick plans to continue investigating these inflammatory mechanisms in collaboration with UVA immunology researcher Coleen McNamara, UVA MRI physicist Frederick Epstein (who developed an MRI method to characterize fatty tissue surrounding the heart), and UVA Director of Cardiac Imaging Amit Patel